Panic disorder (PD) is characterized by abrupt surges of intense fear and distress. There is evidence 21 for a genetic component in this disorder. We ran a meta-analysis of genome-wide association studies 22 of patients with PD, and found 25 single-nucleotide polymorphisms that were associated with the 23 disorder. Causal gene prediction based on these polymorphisms uncovered 20 hits. Exploratory 24 analyses suggested that these genes formed interactor networks, which was enriched in signaling 25 pathways associated with immune and inflammatory responses, as well as growth factors and other 26 developmental mediators. A subset of genes is enriched in limbic regions of the human brain and in 27 microglia and myelinating oligodendrocytes of mice. While these genes were not associated with 28 relevant neurobehavioral phenotypes in mutant mice, expression levels of several causal genes in 29 the amygdala, prefrontal cortex, hippocampus,, hypothalamus, and adrenal gland of recombinant 30 mouse strains was associated with endophenotypes of fear conditioning. Drug repositioning 31 prediction was unsuccessful, but this does not discard these genes and pathways as targets for 32 investigational drugs. In general, ASB3, EIF2S2, RASGRF2, and TRMT2B (and its coded proteins) 33 emerged as interesting targets for mechanistic research on PD. These exploratory findings point 34 towards hypotheses of pathogenesis and neuropharmacology that need to be further investigated. 35 Keywords: Panic disorder; Genome-wide association studies; ASB3; EIF2S; RASGRF2; TRMT2B. 36 37 2012; Hettema et al., 2011; Lotan et al., 2014; Ofrat and Krueger, 2012; Stewart et al., 2015). 53
Introduction 38
Panic disorder (PD) is characterized by repeated and unpredictable panic attacks, usually associated 39 with the development of anticipatory anxiety and avoidance strategies that can culminate in 40 agoraphobia (American Psychiatric Association, 2013) . Patients with PD have high rates of 41 medically unexplained symptoms that produce a burden on healthcare services (Coley et al., 2009). 42 While highly vulnerable to environmental and life-event causes, panic disorder have a significant 43 genetic component. There is evidence of familial aggregation and moderate heritability of PD 44 (~44%) (Merikangas and Pine, 2002) . Many genetic studies have tried to identify linkage or 45 association of specific anxiety disorders with genomic regions or specific genes, but the success rate 46 of such studies is low (Gratacòs et al., 2007) . Different approaches to understand the genetic 47 vulnerabilities associated with anxiety disorders have been proposed, from quantitative trait loci 48 studies and gene expression profiling in animal models (Sokolowska and Hovatta, 2013) , knockout 49 studies in mice (Wood and Toth, 2001) , and genome-wide association studies (GWAS) in humans 50 (Binder, 2012) . Combining different sources of genetic information may help to identify relevant 51 candidate genes and novel drug targets for the treatment of anxiety and stress disorders (Binder, 52 4/23 papers. The reference lists of the retrieved articles were also reviewed to identify publications on 88 the same topic. The published SNPs within 10 kb of a genomic feature (i.e., gene/transcript 89 biotypes) were selected, and protein-coding features were used for the meta-analysis. Table 1  90 presents the selected studies. Data were extracted independently and in duplicate by two reviewers 91 (R.X.C.S and S.P.R.) using a standardized data extraction form. Any disagreement was adjudicated 92 by a third author (C.M.). 93
Meta-analyses were conducted on the basis of the fixed-effect model as implemented by METAL by 94 combining summary statistics across data sets (Willer et al., 2010) . Since meta-analysis of summary 95 statistics is as powerful as pooling individual-level data across studies (Lin and Zeng, 2009), 96 summarized data (SNP identification, reference allele, non-reference allele, and associated p-values) 97 was used. At the meta-analysis level, summary statistics were filtered for inclusion after meeting a 98 minimum imputation quality score of 0.3, minor allele frequency of greater than 0.1% across 99 studies, and absolute β coefficients less than 5. The resulting p-values were corrected for false 100 discovery rates using the R package fdrtool (https://cran.r-project.org/package=fdrtool; Strimmer, 101 2008) . The resulting FDR-corrected trait-associated SNPs (TASs) were filtered based on q-values 102 following a three-sigma rule, with only those TASs that were associated with PD at a q-value 103 smaller than 0.001 retained for posterior analysis. 104
The resulting TASs were analyzed using the PrixFixe method for causal gene prediction (Taşan et 105 al., 2014) ; briefly, the method predicts causal genes based on cofunction networks (using data from 106 shared GO terms, genetic interactions, co-expression, transcription factor binding, protein domains, 107 and protein interactions) to identify functionally related genes. This method gives each putative 108 gene a PF score; higher scores equate stronger confidence of the prediction. TASs were analyzed 109 using 500000 b upstream and downstream padding, and a linkage disequilibrium threshold of r² = 110 0.75, corresponding to 'tightened' genomic regions (Taşan et al., 2014) . Ranks were obtained using 111 version 0.7 of the PrixFixe package for R/Bioconductor 112 (https://llama.mshri.on.ca/~mtasan/GranPrixFixe/html/), and organized per chromosomal region. 113
Only genes with PF scores greater than 0 were retained. These data are available from our GitHub 114 repository (https://github.com/lanec-unifesspa/gwas-pd/tree/master/metanalysis). 115 PF-ranked genes were then compared to candidate genes associated with panic disorder in human 116 patients mined from the GWASdb2 database (http://jjwanglab.org/gwasdb; Li et al., 2012) . These 117 candidate genes are manually mapped to Disease Ontology database ID (DOID) 594, 'panic 118 disorder', and PrixFixe scores were calculated automatically by the database. Genes and PF scores 119 were retrieved, and combined with genes found in our own metanalysis through the use of Venn 120 diagrams. Genes which were shared in both datasets were retained for further analysis. 121
Protein-protein interaction and signalling pathway analyses 123
The Interaction analysis was made for both high-throughput and small-scale physical, undirected 124 interactions, using PathwayLinker (http://pathwaylinker.org/; Farkas et al., 2012) . BioGrid and 125 STRING "exp" databases were used to analyze high-throughput physical interactions, while HPRD 126 was used for small-scale physical interactions between selected proteins and their first neighbors. 127
The resulting set, which was visualized using Cytoscape Web (version 0.8), contained purely 128 physical interactions (i.e., association in complexes, direct interaction, physical interaction, and 129 biochemical co-localization). 130
Signaling pathway analyses were made using PathwayLinker (http://pathwaylinker.org/; Farkas et 131 al., 2012) , using KEGG, Reactome, and SignaLink as databases. Enrichment was considered 132 significant when associated p-values were < 0.001. Both interaction network and signaling pathway 133 data are available from our GitHub repository (https://github.com/lanec-unifesspa/gwas-134 pd/tree/master/pathwaylinker). 135 136
Expression levels in the human brain 137
Using the Allen Human Brain Atlas (http://human.brain-map.org/; Hawrylycz et al, 2012) When more than one array was found, the median was calculated; these data are available from our 145 GitHub repository (https://github.com/lanec-unifesspa/gwas-pd/tree/master/Allen). Data were then 146 analyzed with hierarchical cluster with Euclidean distances and average linkage using Cluster 3.0 147 (University of Tokyo, Japan). Clustering results were then visualized as dendrograms and colored 148 arrays in Java TreeView (University of Glasgow, UK). 149 150
Nervous cell type expression in mouse cortex 151
In order to assess the expression of the candidate genes on specific cell types of the nervous system, 152 a search was made in the Brain RNA-Seq database 153 (https://web.stanford.edu/group/barres_lab/brain_rnaseq.html), which is comprised of RNA 154 sequencing data for acutely purified astrocytes, neurons, oligodendrocyte progenitor cells (OPC), 155 6/23 newly formed oligodendrocytes (NFO), myelinating oligodendrocites (MO), microglia, and 156 endothelial cells derived from the mouse cerebral cortex (Zhang et al., 2014) . These data are 157 available from our GitHub repository (https://github.com/lanec-unifesspa/gwas-158 pd/tree/master/RNA-Seq). Data were expressed as fragments per kilobase of exon per million 159 fragments mapped (FKPM), and, after log transformation, were analyzed with hierarchical cluster 160 with Euclidean distances and average linkage using Cluster 3.0 (University of Tokyo, Japan). 161
Clustering results were then visualized as dendrograms and colored arrays in Java TreeView 162 (University of Glasgow, UK). Each gene was searched in the database, and hit drugs were compiled in a spreadsheet. Following 212 that, the Anatomical Therapeutic Classification (ATC) of each drug was search in the KEGG Drug 213 database (https://www.genome.jp/kegg/drug/). Classification was annotated for the highest level 214 (e.g., N ["Drugs acting on nervous system"] instead of N05 ["Psycholeptics"]). Enrichment tests 215 were performed using Orange3 (Demsar et al., 2018 (Demsar et al., , 2013 , using the χ ² method to test for the 216 association between ATC classification and gene. 217 these filtered SNPs ranged from -5.177 to 4.6, with a median of -1.617 ( Figure S1 ). PF-ranking 224 generated a list of 29 genes with scores above 0 (Table S1 ). PF scores averaged 0.1051 (95% CI 225 0.0801 to 0.1301), similar to values found for candidate genes for breast cancer (Taşan et al., 2014) . 226
In GWASdb2 (Li et al., 2012) , 134 genes with PF scores above 0 were found for the trait "panic 227 disorder" (DOID: 594) (Table S2 ), averaging 0.0775 PF score (95% CI 0.0675 to 0.0875). The 228 intersection between both datasets ( Figure 1A ) revealed 20 genes (ACOT12, AHCY, ASB3, ASIP, 229 CDK19, CENPI, CHAC2, CKMT2, CNTN4, EIF2S2, ERLEC1, GPR75, ITCH, PSME4, RASGRF2, 230 SLC22A16, SOX21, TMEM35, TRMT2B, and ZCCHC9) which were retained for further analyses. A 231 moderate correlation between PF scores from the metanalysis and from GWASdb2 was found (r² = 232 0.781; Figure 1B) . 233 234 235 109 interactor proteins were found for these genes ( Figure  1C ; 236 http://pathwaylinker.org/job.cgi?j=1511525998.96608266998). A major network (network N1) was 237 formed by the interactors of PARD3 (subnetwork S1), ITCH (subnetwork S2), EIF2S2 (subnetwork 238 S3), and CKMT2 (subnetwork S4), linked by SFN, TP53, and UNC119. 3 other networks were 239 found with more than 3 proteins: one involving CDK19 (network N2), one involving RASGRF2 240 (network N4), and one involving ASB3 (network N5). AHCY participated in a small network, with 2 241 other proteins (network N3); 11 genes did not participate in any network. Gonadotropin-releasing hormone (KEGG:hsa04912), NGF (Reactome:R-HSA-166520), and ErbB 248 (KEGG:hsa04012) ( Figure 1D ; http://pathwaylinker.org/job.cgi?j=1511525998.96608266998). 249 250
Protein-protein interaction and signalling pathway analyses

Brain and cell type expression 251
Expression patterns in the human brain were assessed via clustering of microarray data (Figure 2A) . 252
Clustering of brain regions revealed 3 clusters with |r²| The third cluster (r² = 0.821) included white matter and sulci and spaces. Correlations for genes in 259 the hierarchical cluster revealed 3 clusters with |r²| ≥ 0.4. The first cluster (r² = 0.780), with low 260 expression in the limbic cluster, moderate expression in the motor cluster, and very low expression 261 in the white matter and sulci, included ACOT12, ASIP, SLC22A16, CHAC2, TMEM35, and CNTN4. 262 The second cluster (r² = 0.405) included TRMT2B, ERLEC1, CENPI, CDK19, PSME4, EISF2S2, 263 and ASB3, low to moderate expression in the limbic cluster, low expression in the motor cluster, and 264 moderate to high expression in the white matter and sulci. The third cluster (r² = 0.527) included 265 CKMT2, ZCCHC9, ITCH, AHCY, SOX21, and GPR75, which showed low expression in the limbic 266 cluster, high expression in the motor cluster, and low expression in the white matter and sulci. 267 16 of the 20 candidate genes were present in the Brain RNA-Seq database. In general, expression 268 was higher in oligodendrocyte progenitor cells, newly formed cells, and astrocytes and neurons 269 ( Figure 2B ). Hierarchical clustering suggested two clusters with |r²| ≥ 0.5 ( Figure 2C ). The first 270 cluster (r² = 0.676) included Chac2, Cenpi, Trmt2b, Cdk19, Itch, Ahcy, Erlec1, Asb3, Zcchc9, 271 Psme4, and Eif2e2, with lower expression in astrocytes, neurons, OPCs, and NFOs, and higher 272 expression in myelinating oligodendrocites (MOs), microglia, and endothelial cells. The second 273 cluster (r² = 0.556) included Rasgrf2, Tmem35, Gpr75, and Cntn4, with higher expression in 274 astrocytes, neurons, OPCs, and NFOs, and lower expression in MOs, microglia, and endothelial 275 cells. 276 277
Neurobehavioral phenotypes in mice 278
Contrary to expectations, only two of the candidate genes were associated with behavioral or 279 neurological abnormalities in mouse models (Figure 3) . Asip was associated with abnormal food 280 intake and hypoactivity; Itch was associated with neurological abnormalities (tremors and decreased 281 grip strength). The lack of mouse models also demonstrate a literature gap, since only 12 of the 20 282 candidate genes were found in the MGI database. Moreover, it is probable that the published 283 literature studying these genes in mouse mutants did not investigate behavioral phenotypes which 284 are relevant to panic disorder. 285
To further explore the associations between PD candidate genes and neurobehavioral phenotypes, 286
we performed network analyses with mRNA expression data and behavioral traits in the BXD 287 family of recombinant inbred strains. Behavioral and morphological traits showed moderate 288 correlations between each in recombinant inbred mice lineages ( Figures 4A-4E ). BLA glial cell 289 density was negatively correlated with baseline corticorsterone levels (r² = -0.699) and positively 290 correlated with startle response to loud acoustic stimulus (r² = 0.523) and freezing response time to 291 10/23 conditioned cue after 24 (r² = 0.560) and 48 h (r² = 0.685). BLA neuron cell density was negatively 292 correlated with freezing response time to context after 48 h (-0.607) and with baseline 293 corticosterone levels (r² = -0.657). Freezing response time following the final CS-US pairing during 294 training was positively correlated with freezing to conditioned cue after 24 h (r² = 0.543). 295
In the amygdala mRNA probe set, a network with 20 nodes showing |r²| ≥ 0.5 was formed ( Figure  296 4A). A strong negative correlation between Zcchc9 mRNA levels in the amygdala across inbred 297 lineages and freezing to conditioned cue after 24 h (r² = -0.754) was found. Weaker correlations 298 were found between amygdalar Erlec1 mRNA levels and BLA glial density (r² = 0.505); between 299 amygdalar Psme4 mRNA levels and BLA neuron density (r² = 0.576); and between freezing to 300 conditioned cue after 24 h and amygdalar Rasgrf2 (r² = 0.539). 301
In the hippocampus mRNA probe set, a network with 25 nodes showing |r²| Figure 4D) . A moderate negative correlation was found between BLA glial cell density and 320 hypothalamic Chac2 mRNA levels (r² = -0.656). Moderate positive correlations was found between 321 freezing to conditioned cue after 48 h and hypothalamic Trmt2b (r² = 0.550), Itch (r² = 0.563), and 322
Cntn4 (r² = 0.535) mRNA levels. A moderate positive correlation was found between freezing to 323 context and Tmem35 mRNA levels in the hypothalamus (r² = 0.634). 324
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In the adrenal gland mRNA probe set, a network with 24 nodes showing |r²| ≥ 0.5 was formed 325 ( Figure 4E ). Moderate positive correlations were found between BLA neuron density and adrenal 326
Asip (r² = 0.667) and Psme4 (r² = 0.518) mRNA levels, and between BLA glial cell density and 327 adrenal Erlec1 (r² = 0.512) mRNA levels. Negative moderate correlations were found between 328 freezing to conditioned cue after 24 h and adrenal Gpr75 (r² = -0.558) and Asb3 (r² = -0.536) 329 mRNA levels. 330 331
Drug repositioning 332
Top 20 drugs hits after searching the DSigDB database can be found in Figure 5A . No ATC classes 333 were enriched in the set (χ² = 740.62, p = 1, N = 279). No significant enrichment was observed at 334 the drug level (χ² = 5800.41, p = 0.146, N = 549)( Figure 5B) . 335 336 4. Discussion 337
PF ranking 338
None of the candidate genes found here figured in a dataset for six major neuropsychiatric disorders 339 (attention deficit hyperactivity disorder, anxiety disorders, autistic spectrum disorders, bipolar 340 disorder, major depressive disorder, and schizophrenia) (Lotan et al., 2014) . Notably, none of the 341 candidate genes found here figured in a dataset of candidate genes (derived from both human and 342 murine GWAS) for anxiety-spectrum phenotypes, including anxiety disorders, neuroticism, and 343 major depression, as well as anxiety-like behavior in mice (Hettema et al., 2011) . 344 345
Protein-protein interactions and functional associations 346
When mapping the protein-coding candidate genes to a merged and curated BioGRID and HPRD 347 protein-protein interaction database, only 109 proteins, with no interactions between them, were 348 found. Similarly to a cross-disorder set of candidate genes (including genes for ADHD, autistic 349 spectrum disorders, bipolar disorder, major depressive disorder, and schizophrenia; Lotan et al., 350 2014) , thus, the PD dataset does not form an interconnected network at the level of direct protein-351 protein interactions. Despite the lack of direct interactions, core proteins from each network were 352 connected via second interactors for three of the 20 protein-coding genes of the set (ITCH, EIF2S2, 353 and CKMT2). These interactor proteins were involved in the interaction of multiple signaling 354 pathways (SFN), signal transduction in immune cells (UNC119), and cell cyle (TP53). These links 355
were not surprising, since these molecules are overrepresented in the genetics literature (Dolgin, 356 2017) , and since they participate in a wide array of interactions (SFN: n = 126; TP53: n = 342; 357 12/23 UNC119: n = 84); moreover, these proteins have not yet been associated with neuropsychiatric 358 disorders. Therefore, interaction is unlikely to be specific for PD. 359 In spite of this lack of direct protein-protein interaction, important signaling pathways were found 360 to be enriched in the PD dataset and interactor network -including WNT, immune and 361 inflammatory pathways, neurotrophins, EGF/MAFPK, and Rho GTPase pathways. Nonetheless, 362 from the candidate genes only RASGRF2 (which was part of the MAPK, NGF, and Rho GTPase 363 pathways) and ITCH (which was part of Endocytosis, Ubiquitin, and NGF pathways) were part of 364 enriched signaling pathways. Both the MAPK and the Wnt pathways were implicated in threat 365 conditioning and aversive learning in animal models (Maguschak and Ressler, 2011; Schafe et al., 366 2001) . NGF, on the other hand, has been implicated in stress and stress-related psychopathology 367 (Cirulli and Alleva, 2009) . While most of these pathways have been implicated in neural 368 development, mRNA expression of PF-ranked genes in recombinant inbred mice was poorly 369 associated with morphological traits of the BLA; moreover, these associations were more common 370 between BLA morphology and mRNA expression of candidate genes in the HPA axis, and not in the 371 amygdala, as would be expected. Interestingly, Erlec1 and Psme4 expression in both the amygdala 372 and adrenal were associated with BLA morphology. 373 374
Tissue and cell expression 375
Expression patterns in the human brain suggested that most genes were at best moderately 376 expressed in "classical" limbic regions (frontal and cingulate cortices, hippocampus, amygdala); 377 higher expression was found for TRMT2B, ERLEC1, CENPI, CDK19, PSME4, EISF2S2, and ASB3. 378 In rodent PFC cell types, orthologues Trmt2b, Eisf2s2, Cdk19, Erlec1, and Asb3 show higher 379 expression in MOs, microglia, and endothelial cells. These results contrast with a recent GWAS of 380 major depression, in which genes were highly expressed in the frontal and cingulate cortices, 381 hippocampus, and basal ganglia, and significantly enriched in neurons (vs. oligodendrocytes and 382 astrocytes) (Wray et al., 2018) , suggesting disorder-specific patterns. While a region-specific pattern 383 of expression cannot be discarded, these results suggest that MOs and microglial cells in limbic 384 regions are associated with PD. Among these genes only CDK19 and ASB3 appeared in interactor 385 networks (CDK19 was the core of N2), and none was part of the enriched signaling pathways; 386 overall, these results suggest that expression patterns, instead of general function in interactor 387 networks and signalling pathways, is the commonality between these PD-associated genes. 388
When mRNA expression across limbic regions is associated with behavioral traits in rodents, a 389 more specific pattern emerges. Some genes were associated with behavioral traits in fear 390 conditioning paradigms; in all cases, the association was with freezing to cue and/or to context. 391
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Gene expression in the amygdala (Zcchc9, Rasgrf2, Sox10) was associated with freezing to cue 24 h 392 after conditioning, while gene expression in the hypothalamus (Trmt2b, Itch, Cntn4) was associated 393 with freezing to cue 48 h after conditioning. Genes expression in the PFC (Itch, Slc22a16, Sox21) 394 were negatively associated with freezing to context 48 h after conditioning. In the mouse PFC, 395
Zcchc9, Itch, and Trmt2b were expressed mainly in MOs, microglia, and endothelial cells, while 396
Rasgrf2 and Cntn4 were expressed mainly in astrocytes, neurons, OPCs, and NOFs. 397
The higher expression in MOs is of interest, since myelin is known to stabilize synaptic networks, 398 and oligodendrocyte-related proteins have been shown to be modified in the rat dentate gyrus 399 during contextual fear conditioning (Houyoux et al., 2017) . Moreover, microglia has been shown to 400 participate in cued fear conditioning (Parkhurst et al., 2013) , and microglial acid sensing has been 401 shown to participate in carbon dioxide-evoked fear (Vollmer et al., 2016) . These results also make 402 sense in light of the enrichment of immune and inflammatory pathways in the interactor network. 403 404
Drug repositioning attempts 405
Top 20 drugs which perturb PF-ranked genes include interesting findings. Cyclosporin A has been 406 shown to inhibit calcineurin (Fakata et al., 1998) , impairing aversive memory formation in chicks 407 (Bennett et al., 1996) ; and valproic acid enhances the extinction and habituation of fear conditioning 408 in healthy humans (Kuriyama et al., 2011) . Nonetheless, evidence for their use in treating PD (or in 409 exacerbating PD symptoms) is scarce. The current results do not provide sufficient evidence for the 410 association of these drugs and their effects on the PF-ranked genes found for PD; in fact, no gene-411 drug association was found either at the individual drug level, or at the drug class level. Differently 412 from previous reports (So, 2017; So et al., 2016) , which support drug repositioning from genes 413 extracted from GWAS for anxiety and mood disorders, our findings do not support such proposals. 414 Extensive methodological differences are probably responsible for this discrepancy. 415 416
Consequences for the pathophysiology and pharmacology of PD 417
One important limitation of the present results is that they are exploratory in nature, awaiting 418 confirmatory research on all findings. Nonetheless, the present results suggest interesting avenues 419 of investigation on the relationship between genetics and the pathophysiology and pharmacology of 420 PD. First, the observation of cross-species associations between genes discovered in the GWAS 421 metanalysis and neurobehavioral traits of fear prompts the idea of conservation across species of 422 specific endophenotypes (de Mooij-van Malsen et al., 2011; Kas et al., 2012) , such as alterations in 423 fear conditioning (Battaglia and Ogliari, 2005; Bouton et al., 2001) . Second, and perhaps a more 424 interesting point, is the observation that these endophenotypes are not only related to the expression 425 14/23 levels of risk genes in regions such as prefrontal cortex, amygdala, and hypothalamus, but also that 426 these genes are more expressed in myelinating oligodendrocytes and microglia than neurons and 427 astrocytes, the brain cells which are more studied and usually highly associated with psychiatric 428 disorders in GWAS ontology studies (Lotan et al., 2014; Wray et al., 2018) . 429
This last observation ties well with the observation of enrichment in immune and inflammatory 430 pathways, given the role of microglia in these functions in the brain (Hanisch, 2002) . Small studies 431 have suggested increased levels of proinflammatory cytokines in serum from patients with PD (e. 432 g., Hoge et al., 2009) , and cytokines have been associated with acute mental stress in non-clinical 433 populations (Kunz-Ebrecht et al., 2003; Porterfield et al., 2011; Steptoe et al., 2001) . Whether these 434 changes are generalized in PD, and whether genes associated with increased PD risk do so by 435 altering peripheral cytokine responses as well as microglia and oligodendrocyte function in the 436 brain is still unknown. 437
The present results also highlight putative targets for basic pharmacological research. While drug 438 repositioning analysis was inconclusive, experimental drugs acting on these pathways were not part 439 of the dataset. Therefore, the present results point towards an interesting a posteriori hypothesis that 440 targeting specific pathways (WNT, immune and inflammatory responses, neurotrophins, 441 EGF/MAPK, Rho GTPase) specifically in microglia and oligodendrocytes could elucidate the 442 pathophysiology of PD and suggest novel investigational drugs. Further confirmatory research will 443
allow that hypothesis to be tested. 444 445 
